Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 264926, 14 pages
http://dx.doi.org/10.1155/2010/264926
Review Article

Autoantibodies to Tumor-Associated Antigens in Breast Carcinoma

1Department of Obstetrics and Gynecology, Sapir Medical Center, Sackler School of Medicine, University of Tel-Aviv, Kfar-Saba 44281, Israel
2Unit of Gynecologic Oncology, Department of Obstetrics and Gynecology, Soroka Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel

Received 21 July 2010; Revised 4 September 2010; Accepted 19 October 2010

Academic Editor: Aysegula A. Sahin

Copyright © 2010 Ettie Piura and Benjamin Piura. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [33 citations]

The following is the list of published articles that have cited the current article.

  • Bechr Hamrita, Hela Ben Nasr, Philippe Hammann, Lauriane Kuhn, Christelle-Lemaitre Guillier, Anouar Chaieb, Hedi Khairi, and Karim Chahed, “An elongation factor-like protein (EF-Tu) elicits a humoral response in infiltrating ductal breast carcinomas: An immunoproteomics investigation,” Clinical Biochemistry, vol. 44, no. 13, pp. 1097–1104, 2011. View at Publisher · View at Google Scholar
  • Ettie Piura, and Benjamin Piura, “Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma,” Journal of Oncology, 2011. View at Publisher · View at Google Scholar
  • Linlin Liu, Nian Liu, Baogang Liu, Yanming Yang, Qi Zhang, Weijing Zhang, Pengyue Yu, Yonglong Jin, Jia Guo, Songlei Guan, Shilong Sun, Lining Miao, and Jun Wei, “Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 10, pp. 1737–1742, 2012. View at Publisher · View at Google Scholar
  • L. Ye, X. Li, S. Sun, S. Guan, M. Wang, X. Guan, K.-H. Lee, J. Wei, and B. Liu, “A study of circulating anti-CD25 antibodies in non-small cell lung cancer,” Clinical and Translational Oncology, vol. 15, no. 8, pp. 633–637, 2012. View at Publisher · View at Google Scholar
  • Debmalya Barh, Angelo Carpi, Mukesh Verma, Mehmet Gunduz, Sharon O’Toole, Eugen Ancuta, Ream Langhe, Dolores Cahill, Mairead Murphy, Cara Martin, Lynda McEvoy, Cathy Spillane, Orla Sheils, Emmanuel Petricoin, Lance Liotta, and John O’Leary, “Noninvasive Biomarkers in Ovarian Cancer,” Cancer Biomarkers, pp. 615–642, 2013. View at Publisher · View at Google Scholar
  • Dorte Aa. Olsen, Erik H. Jakobsen, and Ivan Brandslund, “Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer,” Clinical Chemistry and Laboratory Medicine, vol. 51, no. 12, pp. 2325–2329, 2013. View at Publisher · View at Google Scholar
  • Chang-Kyu Heo, Hai-Min Hwang, Ah Ruem, Dae-Yeul Yu, Ju Yeon Lee, Jong Shin Yoo, In Gyu Kim, Hyang Sook Yoo, Sejeong Oh, Jeong Heon Ko, and Eun-Wie Cho, “Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer,” International Journal Of Oncology, vol. 42, no. 1, pp. 65–74, 2013. View at Publisher · View at Google Scholar
  • Galit Yahalom, Enrico Cassano, Tanir M Allweis, Arie Bitterman, Pnina Engelman, Luis M Vence, Marvin M Rosenberg, Daria Weiss, Ilya Novikov, Therese B Bevers, Laszlo G Radvanyi, Mei Liu, Benjamin Piura, Stefano Iacobelli, and Maria T Sandri, “An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis.,” Biomarkers in cancer, vol. 5, pp. 71–80, 2013. View at Publisher · View at Google Scholar
  • Weili Wang, Leiguang Ye, Xiaomei Li, Songlei Guan, Shilong Sun, Meng Wang, Xueqing Guan, Kuang-Hui Lee, Jun Wei, and Baogang Liu, “Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer,” Advances in Lung Cancer, vol. 02, no. 04, pp. 79–83, 2013. View at Publisher · View at Google Scholar
  • Gangping Wang, Yan Qin, Junxi Zhang, Jinhui Zhao, Yun'ai Liang, Zuofeng Zhang, Meihua Qin, and Yanqing Sun, “Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer,” International Journal of Molecular Sciences, vol. 15, no. 6, pp. 9546–9565, 2014. View at Publisher · View at Google Scholar
  • Jie Chen, Jie Zhang, Xi Liu, Rui Fang, Yueran Zhao, and Demei Ma, “Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma,” Oncology Reports, vol. 31, no. 6, pp. 2601–2610, 2014. View at Publisher · View at Google Scholar
  • Rick L. Evans, and James V. Pottala, “Classifying Patients for Breast Cancer by Detection of Autoantibodies against a Panel of Conformation-Carrying Antigens,” Cancer Prevention Research, vol. 7, no. 5, pp. 545–555, 2014. View at Publisher · View at Google Scholar
  • Anita Langerod, Magali Olivier, and Anne-Lise Borresen-Dalepp. 147–165, 2014. View at Publisher · View at Google Scholar
  • Weili Wang, Songlei Guan, Shilong Sun, Yonglong Jin, Kuang-Hui Lee, and Jun Wei, “Detection of circulating antibodies to linear peptide antigens derived from ANXA1 and DDX53 in lung cancer,” Tumor Biology, vol. 35, no. 5, pp. 4901–4905, 2014. View at Publisher · View at Google Scholar
  • V.C. Russo, W.J. Azar, S.W. Yau, M.A. Sabin, and G.A. Werther, “IGFBP-2: The dark horse in metabolism and cancer,” Cytokine & Growth Factor Reviews, 2014. View at Publisher · View at Google Scholar
  • Roger R. Beerli, Monika Bauer, Andrea Fritzer, Lindsey B. Rosen, Regula B. Buser, Markus Hanner, Melanie Maudrich, Mario Nebenfuehr, Jorge Alejandro Sepulveda Toepfer, Susanne Mangold, Anton Bauer, Steven M. Holland, Sarah K. Browne, and Andreas Meinke, “Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma,” mAbs, pp. 00–00, 2014. View at Publisher · View at Google Scholar
  • Yile Huang, Cong Zhang, Cairen Chen, Shilong Sun, He Zheng, Shuli Wan, Qingyong Meng, Yubin Chen, and Jun Wei, “Investigation of circulating antibodies to ANXA1 in breast cancer,” Tumor Biology, 2014. View at Publisher · View at Google Scholar
  • Jérôme Lacombe, Alain Mangé, and Jérôme Solassol, “Use of Autoantibodies to Detect the Onset of Breast Cancer,” Journal of Immunology Research, vol. 2014, pp. 1–8, 2014. View at Publisher · View at Google Scholar
  • Petra Leidinger, Andreas Keller, Lisa Milchram, Christian Harz, Martin Hart, Angelika Werth, Hans-Peter Lenhof, Andreas Weinhaeusel, Bastian Keck, Bernd Wullich, Nicole Ludwig, and Eckart Meese, “Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients w,” Plos One, vol. 10, no. 6, 2015. View at Publisher · View at Google Scholar
  • Jie Chen, Zhao Liu, Shuang Fang, Rui Fang, Xi Liu, Yueran Zhao, XiangXin Li, Lei Huang, and Jie Zhang, “Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas,” BMC Cancer, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Ningyan Zhang, Hui Deng, Xuejun Fan, Anneliese Gonzalez, Songlin Zhang, Randall J. Brezski, Byung-Kwon Choi, Michael Rycyzyn, William Strohl, Robert Jordan, and Zhiqiang An, “Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity,” Clinical Cancer Research, vol. 21, no. 23, pp. 5380–5390, 2015. View at Publisher · View at Google Scholar
  • Shankar Suman, Pradeep Kumar Sharma, Girish Rai, Sanjay Mishra, Deepika Arora, Prachi Gupta, and Yogeshwer Shukla, “Current perspectives of molecular pathways involved in chronic Inflammation-mediated breast cancer,” Biochemical and Biophysical Research Communications, 2015. View at Publisher · View at Google Scholar
  • Sharon O’Toole, Eugen Ancuta, Ream Langhe, Mb Chb, Dolores Cahill, Mairead Murphy, Cara Martin, Lynda McEvoy, Cathy Spillane, Orla Sheils, Emmanuel Petricoin, Lance Liotta, and John O’Leary, “Noninvasive Early Biomarkers in Ovarian Cancer,” Noninvasive Molecular Markers in Gynecologic Cancers, pp. 303–336, 2015. View at Publisher · View at Google Scholar
  • Ebru Menekse, John McKolanis, Olivera J. Finn, Priscilla F. McAuliffe, Ronald Johnson, and Atilla Soran, “Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study,” Disease Markers, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • T. M. Allweis, L. Strauss, Z. Malyutin, A. Bassein Kapov-Kagan, I. Novikov, T. B. Bevers, S. Iacobelli, M. T. Sandri, A. Bitterman, P. Engelman, B. Piura, M. Rosenberg, and G. Yahalom, “An Autoantibody Based Protein Microarray Blood Test to Enhance the Specificity of a Negative Screening Mammogram,” Advances in Breast Cancer Research, vol. 04, no. 01, pp. 22–38, 2015. View at Publisher · View at Google Scholar
  • Lance D. Miller, Jonathan Rennhack, Francesco M. Marincola, Michael A. Black, Cristin Print, Julia Chifman, Angela Alistar, Thomas Putti, Davide Bedognetti, Wouter Hendrickx, Ashok Pullikuth, Eran R. Andrechek, Sandra Demaria, Ena Wang, Jeff A. Chou, and Xiaobo Zhou, “Immunogenic subtypes of breast cancer delineated by gene classifiers of immune responsiveness,” Cancer Immunology Research, vol. 4, no. 7, pp. 600–610, 2016. View at Publisher · View at Google Scholar
  • Liu Shi, Yann Chevolot, Eliane Souteyrand, and Emmanuelle Laurenceau, “Autoantibodies against heat shock proteins as biomarkers for the diagnosis and prognosis of cancer,” Cancer Biomarkers, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Anshu Rastogi, Jigisha Srivastav, Denise Young, Isabell A Sesterhenn, Jacob Kagan, Sudhir Srivastava, David G McLeod, Inger L Rosner, Gyorgy Petrovics, Albert Dobi, Shiv Srivastava, Amina Ali, Alagarsamy Srinivasan, Shyh-Han Tan, Sreedatta Banerjee, Yongmei Chen, Jennifer Cullen, Charles P Xavier, Ahmed A Mohamed, and Lakshmi Ravindranath, “Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag.,” Genes & cancer, vol. 7, no. 11-12, pp. 394–413, 2016. View at Publisher · View at Google Scholar
  • Olga Kostianets, Maksym Shyyan, Stepan Vasil’ovich Antoniuk, Valeriy Filonenko, and Ramziya Kiyamova, “Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection,” Biomarkers, pp. 1–8, 2016. View at Publisher · View at Google Scholar
  • Weili Wang, Wen Zhong, Cairen Chen, Qingyong Meng, and Jun Wei, “Circulating antibodies to linear peptide antigens derived from ANXA1 and FOXP3 in lung cancer,” Anticancer Research, vol. 37, no. 6, pp. 3151–3155, 2017. View at Publisher · View at Google Scholar
  • Hardeep Kaur, Nandini Gautam, Anil K. Mantha, and Sunil Mittal, “Biosensors for breast cancer diagnosis: A review of bioreceptors, biotransducers and signal amplification strategies,” Biosensors and Bioelectronics, vol. 88, pp. 217–231, 2017. View at Publisher · View at Google Scholar
  • Yingji Jin, Hyoung Jin Kim, Woong Ju, Seung Cheol Kim, Yun Hwan Kim, and Hong-Jin Kim, “Use of autoantibodies against tumor-associated antigens as serum biomarkers for primary screening of cervical cancer,” Oncotarget, vol. 8, no. 62, pp. 105425–105439, 2017. View at Publisher · View at Google Scholar
  • Oleg Kurtenkov, Kaire Innos, Boris Sergejev, and Kersti Klaamas, “The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer,” BioMed Research International, vol. 2018, pp. 1–8, 2018. View at Publisher · View at Google Scholar